Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Oesch

Showing results (181-190 of 476) with videos related to

Pageof 48
Sort By:
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1987
Individual differences in DNA repair capacities in manF Oesch, W Aulmann, K L Platt, et al.
Environmental Health Perspectives|August 1, 1990
Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamideJ Doehmer, A Seidel, F Oesch, et al.
The Journal of Biological Chemistry|September 25, 1983
Studies on the subunit composition of rat liver glutathione S-transferasesA B Frey, T Friedberg, F Oesch, et al.
Mutation Research|June 1, 1985
Host-mediated mutagenicity experiments with benzo[a]pyrene and two of its metabolitesH Glatt, M Bücker, K L Platt, et al.
International Journal of Cancer|November 15, 1975
Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. I. Differences in mutagenicityH R Glatt, F Oesch, A Frigerio, et al.
Oncogene|February 2, 1999
p16INK4 mediates contact-inhibition of growthR J Wieser, D Faust, C Dietrich, et al.
Current Biology : CB|May 1, 1995
Density-dependent regulation of cell growth by contactinhibin and the contactinhibin receptorG Gradl, D Faust, F Oesch, et al.
Pharmacogenetics|January 1, 1995
Detection of primary DNA damage: applicability to biomonitoring of genotoxic occupational exposure and in clinical therapyF Oesch, J G Hengstler, M Arand, et al.
Carcinogenesis|March 1, 1993
Characterization of DNA adducts at the bay region of dibenz[a,h]anthracene formed in vitroJ Mlcoch, J Fuchs, F Oesch, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1994
The effect of indobufen on the activities of selected rat liver phase I and phase II drug metabolizing enzymes, peroxisomal beta-oxidation and hepatic glutathione statusH Thomas, M Strolin Benedetti, P Dostert, et al.
Pageof 48

Showing results (181-190 of 476) with videos related to

Sort By:
Pageof 48
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1987
Individual differences in DNA repair capacities in manF Oesch, W Aulmann, K L Platt, et al.
Environmental Health Perspectives|August 1, 1990
Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamideJ Doehmer, A Seidel, F Oesch, et al.
The Journal of Biological Chemistry|September 25, 1983
Studies on the subunit composition of rat liver glutathione S-transferasesA B Frey, T Friedberg, F Oesch, et al.
Mutation Research|June 1, 1985
Host-mediated mutagenicity experiments with benzo[a]pyrene and two of its metabolitesH Glatt, M Bücker, K L Platt, et al.
International Journal of Cancer|November 15, 1975
Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. I. Differences in mutagenicityH R Glatt, F Oesch, A Frigerio, et al.
Oncogene|February 2, 1999
p16INK4 mediates contact-inhibition of growthR J Wieser, D Faust, C Dietrich, et al.
Current Biology : CB|May 1, 1995
Density-dependent regulation of cell growth by contactinhibin and the contactinhibin receptorG Gradl, D Faust, F Oesch, et al.
Pharmacogenetics|January 1, 1995
Detection of primary DNA damage: applicability to biomonitoring of genotoxic occupational exposure and in clinical therapyF Oesch, J G Hengstler, M Arand, et al.
Carcinogenesis|March 1, 1993
Characterization of DNA adducts at the bay region of dibenz[a,h]anthracene formed in vitroJ Mlcoch, J Fuchs, F Oesch, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1994
The effect of indobufen on the activities of selected rat liver phase I and phase II drug metabolizing enzymes, peroxisomal beta-oxidation and hepatic glutathione statusH Thomas, M Strolin Benedetti, P Dostert, et al.
Pageof 48